THE COMBINATION OF VENETOCLAX AND FTY720 HAS A SYNERGISTIC PRO-APOPTOTIC EFFECT IN ACUTE MYELOID LEUKEMIA

被引:0
|
作者
Irene, Peris [1 ]
Elena, Martinez-Balsalobre [2 ]
Elena, Arriazu [3 ]
Silvia, Romero-Murillo [1 ]
Javier, Marco [1 ]
Nerea, Marcotegui [4 ]
Andrea, Torres-Lopez [5 ]
Carmen, Mateos M. [5 ]
Luisa, Cayuela M. [2 ]
Dolores, Odero M. [1 ]
Carmen, Vicente [1 ]
机构
[1] Univ Navarra, Pamplona, Spain
[2] Inst Murciano Invest Biosanitaria, Murcia, Spain
[3] Inst Salud Carlos III, Madrid, Spain
[4] CIMA Univ Navarra, Pamplona, Spain
[5] Complejo Hosp Navarra, Pamplona, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CO-071
引用
收藏
页码:53 / 54
页数:2
相关论文
共 50 条
  • [41] VENETOCLAX IN COMBINATION AS A TREATMENT OF ACUTE MYELOID LEUKEMIA IN RECALLED OR REFRACTORY PATIENTS
    Hernandez Jasson, Villarreal
    Esteve Maria, Condom
    Marin Helena, Pomares
    Polo Susana, Vives
    Jorda Rosa, Coll
    Calvo Marta, Cervera
    Artigal Clara, Maluquer
    Fernandez Gladys, Ibarra
    Albert, Torrent
    Barajas Mercedes, Galiano
    Balari Anna, Sureda
    Sangerman Montserrat, Arnan
    HAEMATOLOGICA, 2021, 106 (10) : 215 - 215
  • [42] FTY720 Induces Apoptosis of M2 Subtype Acute Myeloid Leukemia Cells by Targeting Sphingolipid Metabolism and Increasing Endogenous Ceramide Levels
    Chen, Limin
    Luo, Liu-Fei
    Lu, Junyan
    Li, Lianchun
    Liu, Yuan-Fang
    Wang, Jiang
    Liu, Hong
    Song, Heng
    Jiang, Hualiang
    Chen, Sai-Juan
    Luo, Cheng
    Li, Keqin Kathy
    PLOS ONE, 2014, 9 (07):
  • [43] Treatment with Oral Fingolimod (FTY720), 0.5 or 1.25 mg, for 14 Days Has No Effect on Airway Resistance
    Schmouder, Robert
    Liu, Cherrie
    David, Olivier J.
    Wang, Nan
    NEUROLOGY, 2009, 72 (11) : A238 - A238
  • [44] Synergistic efficacy of homoharringtonine and venetoclax on acute myeloid leukemia cells and the underlying mechanisms
    Yuan, Fangfang
    Li, Dongbei
    Li, Gangping
    Cheng, Cheng
    Wei, Xudong
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (08)
  • [45] AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia
    V Barbetti
    I Tusa
    M G Cipolleschi
    E Rovida
    P Dello Sbarba
    Cell Death & Disease, 2013, 4 : e536 - e536
  • [46] AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia
    Barbetti, V.
    Tusa, I.
    Cipolleschi, M. G.
    Rovida, E.
    Dello Sbarba, P.
    CELL DEATH & DISEASE, 2013, 4 : e536 - e536
  • [47] Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia
    Zhou, Fang-jiao
    Zeng, Chen-xing
    Kuang, Wei
    Cheng, Cong
    Liu, Hong-cai
    Yan, Xue-ying
    Chen, Xiao-ping
    Zhou, Gan
    Cao, Shan
    JOURNAL OF CANCER, 2021, 12 (22): : 6727 - 6739
  • [48] Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination
    Thomas E. Lew
    John F. Seymour
    Journal of Hematology & Oncology, 15
  • [49] FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
    Neviani, Paolo
    Santhanam, Ramasamy
    Oaks, Joshua J.
    Eiring, Anna M.
    Notari, Mario
    Blaser, Bradley W.
    Liu, Shujun
    Trotta, Rossana
    Muthusamy, Natarajan
    Gambacorti-Passerini, Carlo
    Druker, Brian J.
    Cortes, Jorge
    Marcucci, Guido
    Chen, Ching-Shih
    Verrills, Nicole M.
    Roy, Denis C.
    Caligiuri, Michael A.
    Bloomfield, Clara D.
    Byrd, John C.
    Perrotti, Danilo
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (09): : 2408 - 2421
  • [50] A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
    Vicente, Carmen
    Arriazu, Elena
    Martinez-Balsalobre, Elena
    Peris, Irene
    Marcotegui, Nerea
    Garcia-Ramirez, Patricia
    Pippa, Raffaella
    Rabal, Obdulia
    Oyarzabal, Julen
    Guruceaga, Elizabeth
    Prosper, Felipe
    Mateos, Maria C.
    Cayuela, Maria L.
    Odero, Maria D.
    CANCER LETTERS, 2020, 468 : 1 - 13